Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CERTOLIZUMAB PEGOL vs GOLIMUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CERTOLIZUMAB PEGOL vs GOLIMUMAB: Safety Overview

Metric CERTOLIZUMAB PEGOL GOLIMUMAB
Total FAERS Reports 99,098 69,222
Deaths Reported 5,361 4,866
Death Rate 5.4% 7.0%
Hospitalizations 17,641 15,471
Average Patient Age 49.5 yrs 53.0 yrs
% Female Patients 83.1% 79.2%
Manufacturer UCB, Inc. Janssen Biotech, Inc.
Route SUBCUTANEOUS INTRAVENOUS
Marketing Status Prescription Prescription